Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

A Spotlight on IgG4-Related Disease

Emine Atac, MD, and John H. Stone, MD, MPH  |  January 1, 2013

What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)

Filed under:ConditionsOther Rheumatic ConditionsResearch RheumSjögren’s Disease Tagged with:ClinicalfibroinflammatoryIgG4-RDSjogren's

ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront

Mary Beth Nierengarten  |  January 1, 2013

Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights

Filed under:ConditionsMeeting ReportsPsoriatic ArthritisRheumatoid Arthritis Tagged with:ACR/ARHP Annual MeetingPsoriatic ArthritisRA flaresRheumatoid arthritis

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2013

Information on new approvals and medication safety rheumatologists need to know

Filed under:Drug Updates Tagged with:adalimumabDrugsFDAguidelineSafety

Coding Corner Question: December

Staff  |  December 1, 2012

Test your coding knowledge for an office visit by a 60-year-old patient with severe rheumatoid arthritis who has an adverse reaction to an infliximab infusion, requiring her IV to be flushed with saline and pushed with diphenhydramine.

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingdruginfliximabMethotrexatePractice Managementprednisonerheumatologist

What Rheumatologists Should Look for in Diagnosing SAPHO Syndrome

Richard Brasington, MD  |  November 1, 2012

SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is an obscure condition that can vex patients and clinicians

Filed under:Clinical Criteria/GuidelinesConditionsOsteoarthritis and Bone Disorders Tagged with:anti-inflammatorybonecase reportimaginginfliximabPainpatient careradiographrheumatologistSAPHOsynovitisTreatment

As Population Ages, Rheumatologists Prepare to Treat Elderly Patients with More Comorbidities

Vanessa Caceres  |  November 1, 2012

Cardiovascular disease, diabetes are among the conditions that add another layer of complexity in treating older rheumatology patients

Filed under:Clinical Criteria/GuidelinesConditionsGout and Crystalline ArthritisOsteoarthritis and Bone DisordersRheumatoid Arthritis Tagged with:anti-inflammatorydruggeriatricGoutHYDROXYCHLOROQUINEOsteoarthritispatient carepatient communicationPatientsPractice ManagementRheumatoid arthritisTreatmentvaccine

Rheumatology Drug Updates: Apremilast, Golimumab, and More

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2012

Information on new approvals and medication safety rheumatologists need to know

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:Ankylosing SpondylitisBiologicsBiosimilarsdrugFDAinfliximabJAK inhibitorsjanus kinaseMethotrexatePipelinePolymyalgia RheumaticaprednisonePsoriatic ArthritisRheumatoid arthritisSafetyTofacitinib

Treat to Target: Rheumatoid Arthritis in Pregnant Patients

Eliza F. Chakravarty, MD, MS  |  October 1, 2012

A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiologicsdrugMethotrexatepatient carepregnancyRheumatoid arthritis

EULAR: Identify Arthritis Early, Treat it Effectively

Thomas R. Collins  |  October 1, 2012

Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis

Filed under:ConditionsEULAR/OtherMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:EULARInternationalJuvenile idiopathic arthritispatient carePediatricsResearchRheumatoid arthritisrheumatologist

Maintenance of Remission in ANCA-Associated Vasculitis

Paul A. Monach, MD, PhD  |  September 5, 2012

Relapses are common, but difficult to predict and prevent.

Filed under:ConditionsResearch RheumVasculitis Tagged with:ANCA-Associated VasculitisdrugGlucocorticoidsgranulomatosis with polyangiitisMethotrexatepatient careResearchrheumatologistrituximabVasculitis

  • « Previous Page
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences